KLF4 and atherosclerosis: Moreover, in the HFD ApoEKO mouse atherosclerosis model, VSMC-specific conditional KO of KLF4 resulted in reduced lesion size, increased fibrous cap thickness, and major reductions in the fraction of VSMC-derived MØ- and MSC-like cells.